BD 329461 - Insulin Syringe 0.5cc U-100 with 28G x " Lo-Dose Micro-Fine IV Sterile, Latex-Free Syringe for Precise Insulin Delivery, 100/BX, 5 BX/CA
TheBD 329461 Syringeis a0.5cc U-100 insulin syringefeaturing an ultra-fine28-gauge x -inch needleandLo-Dose Micro-Fine IVtechnology, engineered for accurate and comfortable subcutaneous insulin administration. Designed for use by patients with diabetes or healthcare professionals managing insulin therapy, this syringe delivers precision dosing for effective blood glucose control.
Manufactured byBD (Becton, Dickinson and Company)a leader in injection technologiesthis insulin syringe issterile, latex-free, andsingle-use, ensuring hygienic and safe application. Its clear, easy-to-read scale supports accurate measurement, especially critical for low-dose regimens.
Key Product Features
| Hub Color | Clear |
| Hub Material | Polypropylene |
| Hub Type | Rounded |
| Needle Gauge | 28 G |
| Needle Gauge (m) | 0.36 mm |
| Needle Length (in.) | 1/2 in. |
| Needle Length (m) | 12.70 mm |
| Needle Tip Type | 3-bevel |
| Needle Type | Insulin |
| Needle Wall Type | Regular |
| Syringe Scale | 1 mL graduations |
| Sterile | Sterilized product |
| Sterilization Method | Gamma radiation |
| Disposable | Disposable product |
| Single Use | Product is for single use only |
Key Benefits:
Lo-Dose 0.5cc Capacity: Ideal for patients requiring smaller or precise insulin doses.
28G x " Ultra-Fine Needle: Reduces pain and improves injection comfort for daily use.
U-100 Insulin Compatibility: Calibrated specifically for U-100 insulin formulations.
Micro-Fine IV Technology: Engineered for smoother needle insertion and consistent flow.
Latex-Free & Sterile: Minimizes allergy risk and ensures aseptic use in clinical and personal environments.
Clear Graduations: Easy-to-read scale supports safe and confident self-dosing.
Compatibility and Applications:
This syringe is compatible exclusively withU-100 insulinand is intended forsubcutaneous administration. It is used across:
Hospitals and endocrinology clinics
Home diabetes care and self-administration
Assisted living and long-term care facilities
Pharmacies offering insulin support services
Typical applications include:
Daily insulin therapy for Type 1 or Type 2 diabetes
Insulin titration and correction dosing
Pediatric or geriatric diabetic management
Low-dose, high-frequency insulin regimens
Usage Guidelines:
Use a new syringe for each injection to maintain sterility and accuracy.
Verify insulin type and dose before drawing.
Insert the needle subcutaneously per your healthcare providers instructions.
Dispose of the syringe in an FDA-cleared sharps disposal container immediately after use.
For detailed self-injection technique, refer to instructions provided with your insulin or consult your care team.
Certifications, Safety Standards, and Regulatory Approvals:
FDA Approvedfor insulin administration
CE Markedfor compliance with European safety standards
ISO 13485 Certified: Manufactured under medical-grade quality systems
Latex-Free and DEHP-Free: Designed to reduce allergy and chemical sensitivities
These certifications ensure the BD 329461 meets the highest safety and quality requirements in diabetic care.
Comparison with Competitor Products:
TheBD 329461 Lo-Dose Syringestands out for its:
Ultra-fine needle and Micro-Fine technology, delivering minimal pain
Superior scale clarity, enhancing accuracy for low-dose injections
Reliable glide action, reducing resistance during insulin draw and delivery
Latex-free assurance, ensuring universal patient compatibility
In contrast, many generic syringes may lack needle precision, scale visibility, or smooth glide, increasing dosing errors or injection discomfort.
Typical User Profile and Application Scenarios:
Ideal users include:
Adults and children managing Type 1 or Type 2 diabetes
Elderly patients on low-dose insulin therapy
Healthcare professionals in hospitals, diabetes clinics, or pharmacies
Caregivers administering insulin in home or assisted care environments
Use cases:
Daily basal or bolus insulin injections
Correction dosing before/after meals
Tight glycemic control in pediatric patients
Insulin-sensitive patients requiring precise microdosing
Best Practices for Use and Maintenance:
Always inspect syringe packaging before use
Store syringes at room temperature in a clean, dry area
Do not share or reuse syringes to prevent infection and dosage error
Use a sharps container for disposalnever throw syringes in regular trash
Educate patients or caregivers on safe handling and disposal protocols
Device Characteristics
| What MRI safety information does the labeling contain? | Labeling does not contain MRI Safety Information |
| Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801.437) | No |
| Device labeled as "Not made with natural rubber latex" | No |
| For Single-Use | Yes |
| Prescription Use (Rx) | No |
| Over the Counter (OTC) | No |
| Kit | No |
| Combination Product | No |
| Human Cell, Tissue or Cellular or Tissue-Based Product (HCT/P) | No |
Regulatory and Safety Information:
The BD 329461 is fully compliant withCDC,FDA, andADAinsulin administration guidelines. Its Lo-Dose and Micro-Fine IV design support safe, consistent, and low-resistance injectionscritical for those on intensive insulin therapy.
Product Packaging Information
| Packaging Level | Shelfpack | Each | Case |
| Quantity | 100 | 1 | 500 |
| Length | 16.51 cm | 692.15 mm | |
| Width | 16.51 cm | 177.8 mm | |
| Height | 13.335 cm | 184.15 mm | |
| Weight | 440.0 g | 4.073 g | 2.54 kg |
How to Order:
To purchase theBD 329461 0.5cc Insulin Syringe with 28G x " Needle, follow these steps:
Navigate to the product in the CIA Medical catalog
Select the desired quantity and click Add to Cart
Proceed through the secure checkout process
Forbulk orders, diabetic supply programs, or further assistance, contact CIA Medical customer service at(312) 275-5850or use the contact form on this page. Our knowledgeable team is here to support your insulin delivery needs with speed and precision.
